<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02427074</url>
  </required_header>
  <id_info>
    <org_study_id>1180/09</org_study_id>
    <nct_id>NCT02427074</nct_id>
  </id_info>
  <brief_title>Comparison Between Radiofrequency and Balloon Compression in the Treatment of Idiopathic Trigeminal Neuralgia</brief_title>
  <official_title>Comparative Study Between Radiofrequency and Balloon Compression of the Gasserian Ganglion in the Treatment of Idiopathic Trigeminal Neuralgia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Two percutaneous procedures used in the treatment of idiopathic trigeminal neuralgia are
      analysed. The effects on pain relief, alterations in cutaneous sensibility and olfactory and
      salivatory functions are analysed as well.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients diagnosed with idiopathic trigeminal neuralgia, refractory or intolerant to medical
      treatment, are randomly assigned (after signing a consent form), to receive one of two
      percutaneous procedures. The patients are evaluated a week before and a week, a month, two
      months, three months and six months after the surgery.

      The questionnaires (Short-Form of the McGill Pain Questionnaire - SF-MPQ, Douleur
      Neuropathique - DN4, Neuropathic Pain Symptom Inventory - NPSI, Brief Pain Inventory - BPI,
      Global Clinical Impression - GCI, Hospital Anxiety and Depression - HAD, Brief World Health
      Organization Quality of Life Questionnaire - WHOQOL-brief, Pain Catastrophizing Scale - PCS)
      and tests (Quantitative Sensory Testing - QST, olfactory threshold - OT - and discrimination
      - OD, taste threshold - TT, and salivatory quantification - SQ) are applied as follows:

        -  Pre-op evaluation: SF-MPQ, DN4, BPI, NPSI, HAD, WHOQOL-brief, PCS, QST, OT, OD, TT, SQ.

        -  First visit post-op: SF-MPQ, BPI, NPSI, GCI

        -  Second visit post-op: SF-MPQ, BPI, NPSI, GCI

        -  Third visit post-op: SF-MPQ, BPI, NPSI, GCI

        -  Fourth visit post-op: SF-MPQ, DN4, BPI, NPSI, GCI, WHOQOL-brief, HAD, PCS, QST, OT, TT,
           SQ.

        -  Fifth visit post-op: SF-MPQ, DN4, BPI, NPSI, GCI, WHOQOL-brief, HAD, PCS, QST, OT, OD,
           TT, SQ.

      Patients with pain recurrence are excluded after the last visit attended. An exploratory
      analysis is made with 30 patients for a proper sample size calculation during the study.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain relief using the visual analogic scale</measure>
    <time_frame>6 months</time_frame>
    <description>Average pain using the visual analogic scale in the Brief Pain Inventory</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in how the pain is perceived by the patient assessed by the Short-Form of the McGill Pain Questionnaire</measure>
    <time_frame>6 months</time_frame>
    <description>Short-Form of the McGill Pain Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in neuropathic pain quality assessed by Douleur Neuropatique 4</measure>
    <time_frame>6 months</time_frame>
    <description>Douleur Neuropatique 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of chronic pain and its influence in patients life assessed by Brief Pain Inventory</measure>
    <time_frame>6 months</time_frame>
    <description>Brief Pain Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in types of symptoms of neuropathic pain assessed by Neuropathic Pain Symptom Inventory</measure>
    <time_frame>6 months</time_frame>
    <description>Neuropathic Pain Symptom Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in quality of life assessed by World Health Organization Quality of Life - brief form</measure>
    <time_frame>6 months</time_frame>
    <description>World Health Organization Quality of Life - brief form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Both patient and investigator impression in the treatment assessed by Global Clinical Impression</measure>
    <time_frame>6 months</time_frame>
    <description>Global Clinical Impression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of how pain affects patients perception assessed by Pain Catastrophizing Scale</measure>
    <time_frame>6 months</time_frame>
    <description>Pain Catastrophizing Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Onset of changes in anxiety or depression assessed by Hospital Anxiety and Depression</measure>
    <time_frame>6 months</time_frame>
    <description>Hospital Anxiety and Depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantification of facial sensibility changes assessed by Quantitative Sensorial Testing</measure>
    <time_frame>6 months</time_frame>
    <description>Quantitative Sensorial Testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in olfactory threshold assessed by isopropanol solution</measure>
    <time_frame>6 months</time_frame>
    <description>Olfactory Threshold using isopropanol solution</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in gustatory threshold assessed using sweet, sour, salty and bitter solutions</measure>
    <time_frame>6 months</time_frame>
    <description>Gustatory Threshold using sweet, sour, salty and bitter solutions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in salivary flow assessed using cotton weights</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluation of salivary flow using cotton weights</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in olfactory discrimination assessed using Sniffin' Sticks</measure>
    <time_frame>6 months</time_frame>
    <description>Using Sniffin' Sticks to evaluate olfactory discrimination</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Trigeminal Neuralgia</condition>
  <arm_group>
    <arm_group_label>Balloon Compression Rhizotomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients that are submitted to Balloon Compression Rhizotomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Radiofrequency Thermal Coagulation Rhizotomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients that are submitted to Radiofrequency Thermal Coagulation Rhizotomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Balloon Compression Rhizotomy</intervention_name>
    <description>The balloon compression rhizotomy is performed in a percutaneous fashion where a Fogarty catheter is positioned in the gasserian ganglion and inflated with 0,7 milliliters of radiopaque dye during 120 seconds.</description>
    <arm_group_label>Balloon Compression Rhizotomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radiofrequency Thermal Coagulation Rhizotomy</intervention_name>
    <description>The gasserian ganglion is submitted to a controlled thermal coagulation with a electrode with 80 Celsius degrees of temperature during 60 seconds on the specific division.</description>
    <arm_group_label>Radiofrequency Thermal Coagulation Rhizotomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Idiopathic Trigeminal Neuralgia

          -  Refractory/Intolerable medical treatment

          -  Pain restricted to second or third trigeminal division

        Exclusion Criteria:

          -  Secondary Trigeminal Neuralgia

          -  Pain restricted to the first trigeminal division

          -  Refuse to participate

          -  Unable to comprehend the questionnaires
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Ciampi, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>HCFMSUP</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>HCFMSUP</name>
      <address>
        <city>SÃ£o Paulo</city>
        <state>SP</state>
        <zip>05403000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 18, 2015</study_first_submitted>
  <study_first_submitted_qc>April 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2015</study_first_posted>
  <last_update_submitted>March 17, 2018</last_update_submitted>
  <last_update_submitted_qc>March 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Hugo Sterman Neto</investigator_full_name>
    <investigator_title>medical doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuralgia</mesh_term>
    <mesh_term>Trigeminal Neuralgia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

